| Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection (NCT03400293) | ViiV Healthcare | 2018-01-18 |
| Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants (NCT03122223) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-01-16 |
| PrEP Implementation for Mothers in Antenatal Care (NCT03070600) | University of Washington | 2018-01-15 |
| Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) (NCT03391921) | Centre Hospitalier Universitaire Saint Pierre | 2018-01-08 |
| VioOne HIV Profile Supplemental Assay (NCT03727932) | Avioq, Inc. | 2018-01-03 |
| Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD) (NCT03369743) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2018-01-02 |
| Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) (NCT05002907) | Centre Hospitalier de Cayenne | 2018-01-01 |
| Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe (NCT04206241) | Elizabeth Glaser Pediatric AIDS Foundation | 2018-01-01 |
| Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar (NCT03579576) | Right to Care | 2017-12-20 |
| Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) (NCT03368053) | GlaxoSmithKline | 2017-12-14 |
| 30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes (NCT03353701) | University of Florida | 2017-12-11 |
| Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks (NCT03293290) | Yale University | 2017-12-11 |
| Evaluation of Artemisia Annua and Moringa (NCT03366922) | Mbarara University of Science and Technology | 2017-12-10 |
| Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2) (NCT03369249) | New York State Psychiatric Institute | 2017-12-09 |
| Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE) (NCT04641013) | Kirby Institute | 2017-12-05 |
| An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) (NCT03157167) | Navidea Biopharmaceuticals | 2017-12-01 |
| Dolutegravir and Darunavir Evaluation in Adults Failing Therapy (NCT03017872) | Kirby Institute | 2017-11-23 |
| Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in Botswana (NCT03336346) | Columbia University | 2017-11-15 |
| Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social Media (NCT03404531) | Brown University | 2017-11-10 |
| Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women (NCT03164564) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-11-07 |
| Get Connected Efficacy Trial (NCT03132415) | University of Pennsylvania | 2017-11-01 |
| Study to Determine Therapeutic Massage Dosing to Improve Quality of Life in Hospitalized Patients Receiving Palliative Care (NCT04916223) | Medstar Health Research Institute | 2017-11-01 |
| Strategies to Improve the HIV Care Continuum Among Key Populations in India (NCT02969915) | Johns Hopkins University | 2017-10-30 |
| Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults (NCT03299049) | ViiV Healthcare | 2017-10-27 |
| Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional Incentives (NCT03808194) | University of Washington | 2017-10-26 |
| Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (NCT03239483) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-26 |
| A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults (NCT03205917) | International AIDS Vaccine Initiative | 2017-10-23 |
| Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA (NCT03181789) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-18 |
| Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal (NCT03367130) | Tokyo University | 2017-10-14 |
| Brief Electronic Intervention for Heavy Drinking and Sex Risk Among MSM Seeking HIV Testing (NCT03435783) | Brown University | 2017-10-13 |
| Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men (NCT03320239) | National Center for AIDS/STD Control and Prevention, China CDC | 2017-10-12 |
| Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners (NCT03271307) | University of California, Los Angeles | 2017-09-25 |
| GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers (NCT03231943) | ViiV Healthcare | 2017-09-19 |
| Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland (NCT03397420) | Elizabeth Glaser Pediatric AIDS Foundation | 2017-09-13 |
| Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS (NCT03141918) | Universidade Federal do Rio Grande do Norte | 2017-09-08 |
| A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study (NCT03067285) | Fundacion SEIMC-GESIDA | 2017-09-08 |
| Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients (NCT03256422) | ANRS, Emerging Infectious Diseases | 2017-09-07 |
| Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection (NCT03854630) | National Taiwan University Hospital | 2017-09-06 |
| PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation (NCT03253757) | St Stephens Aids Trust | 2017-09-01 |
| Impact of Different Integrase Inhibitor Based Regimen on Immune Activation Among HIV naïve Patient (INTATTI) (NCT03280940) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2017-09-01 |
| Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men (NCT03310515) | ViiV Healthcare | 2017-08-31 |
| Tailored Motivational Interviewing Implementation-Effectiveness Trial in Multidisciplinary Adolescent HIV Care Settings (NCT03681912) | Florida State University | 2017-08-28 |
| Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults (NCT03220724) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-08-22 |
| Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA (NCT03153709) | University of North Carolina, Chapel Hill | 2017-08-17 |
| Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART (NCT03198559) | University of Melbourne | 2017-08-08 |
| A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir (NCT03234036) | GlaxoSmithKline | 2017-08-02 |
| Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ Recipients (NCT03408106) | Johns Hopkins University | 2017-08-01 |
| Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study (NCT03238755) | Massachusetts General Hospital | 2017-07-31 |
| Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals (NCT03215004) | American Gene Technologies International Inc. | 2017-07-25 |
| Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV (NCT03296202) | University Hospital, Bordeaux | 2017-07-18 |
| Client and Provider Preferences for HIV Care (NCT03216798) | Thai Red Cross AIDS Research Centre | 2017-07-15 |
| STI Screening as a Combined HIV Prevention Platform for MSM in Peru (NCT03010020) | University of California, Los Angeles | 2017-07-15 |
| HIV&HEART Aging Study (12,5 Year Follow up) (NCT04156048) | University Hospital, Essen | 2017-07-03 |
| A Randomized Trial to Prevent HIV Among Gay Couples (NCT03189394) | San Francisco State University | 2017-07-01 |
| Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine (NCT03284710) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-19 |
| Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers (NCT03383211) | George Washington University | 2017-06-16 |
| Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019 (NCT03016533) | ViiV Healthcare | 2017-06-06 |
| Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects (NCT03149848) | ViiV Healthcare | 2017-06-06 |
| Evaluating the Feasibility of Point of Care Birth Testing in Eswatini (NCT04206878) | Elizabeth Glaser Pediatric AIDS Foundation | 2017-06-01 |
| Tripe Versus Dual Antiretroviral Therapy in HIV-infected Patients With Virological Suppression (Tridual) (NCT03447873) | Hospitales Universitarios Virgen del Rocío | 2017-06-01 |
| Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention (NCT03144336) | RAND | 2017-05-24 |
| Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial (NCT03149757) | University of Minnesota | 2017-05-16 |
| Prevention of HIV in "Île-de-France" (NCT03113123) | ANRS, Emerging Infectious Diseases | 2017-05-03 |
| Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir (NCT03095638) | ViiV Healthcare | 2017-05-03 |
| A Comparison of Different Community Models of ART Delivery Amongst Stable HIV+ Patients in Two Urban Settings in Zambia (NCT03025165) | HIV Prevention Trials Network | 2017-05-01 |
| A Smartphone Application to Support Physical Activity in HIV Infected People (NCT03098095) | Scientific Institute San Raffaele | 2017-04-26 |
| Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE) (NCT02904733) | Hospital Clinic of Barcelona | 2017-04-07 |
| iHIVARNA Clinical Trial in HIV Infected Individuals (NCT02888756) | Rob Gruters | 2017-04-04 |
| Prevalence of Cutaneous Autoimmune Phenomena in HIV Infected Patients (NCT03129308) | Medical University of Vienna | 2017-04-03 |
| Pilot Study of HIV and Hepatitis B and C Screening in Surgery (NCT03088995) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2017-04-01 |
| Men's Club: Impact of Male Partner Involvement on Initiation and Sustainment of Exclusive Breastfeeding Among Postpartum Women (NCT03072758) | University of Nevada, Las Vegas | 2017-03-30 |
| A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults (NCT02990325) | Abivax S.A. | 2017-03-27 |
| Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection. (NCT03161444) | University Hospital Center of Martinique | 2017-03-21 |
| Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults (NCT03045861) | GlaxoSmithKline | 2017-03-17 |
| The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER) (NCT03049176) | University of California, San Francisco | 2017-03-13 |
| Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults (NCT02797171) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-01 |
| Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers (NCT02478463) | ViiV Healthcare | 2017-02-27 |
| A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV (NCT03210701) | Memorial University of Newfoundland | 2017-02-14 |
| Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities (NCT02985996) | Emory University | 2017-02-06 |
| Impact of HIV-1 and Aging on Mucosal Vaccine Responses (NCT03729778) | VA Eastern Colorado Health Care System | 2017-01-18 |
| Epidemiological Study of the Markers of Aging in the Cohort of Patient HIV in Brest (NCT06554210) | University Hospital, Brest | 2017-01-08 |
| Gut and Vaginal Microbiota Profile Study for HIV Women (NCT05996016) | Peking Union Medical College Hospital | 2017-01-01 |
| Development and Implementation of an HIV-testing Intervention for Primary Care in Belgium (NCT04056156) | Institute of Tropical Medicine, Belgium | 2017-01-01 |
| Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community (NCT04947475) | Yale University | 2017-01-01 |
| Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients (NCT02741323) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-01-01 |
| Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205 (NCT02852005) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-01-01 |
| Nevirapine + 3TC Based Maintenance Therapy for HIV Infection (NCT03223402) | Cantonal Hospital of St. Gallen | 2016-12-23 |
| Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice (NCT03042390) | Fundacion SEIMC-GESIDA | 2016-12-23 |
| Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men (NCT02720094) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-19 |
| Phase 4 Study of Dolutegravir (DTG) in Russian Federation (NCT03314064) | ViiV Healthcare | 2016-12-08 |
| Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults (NCT02915016) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-07 |
| Piloting At-birth Point of Care HIV Testing Strategies in Kenya (NCT03435887) | University of Kansas Medical Center | 2016-12-02 |
| Integrating HIV and Depression Self-Care to Improve Adherence in Perinatal Women (NCT03016546) | Yale University | 2016-12-01 |
| Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG (NCT03198962) | Thai Red Cross AIDS Research Centre | 2016-11-15 |
| Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection (NCT03158077) | Fundacion SEIMC-GESIDA | 2016-11-15 |
| Development of a Tailored HIV Prevention Intervention for Young Men (NCT02842060) | University of Pennsylvania | 2016-11-01 |
| Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults (NCT02951052) | ViiV Healthcare | 2016-10-28 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (NCT02938520) | ViiV Healthcare | 2016-10-27 |
| Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa (NCT02968849) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-10-26 |
| Advancing HIV Prevention and Linkage to Care Among MSM With Gamification (NCT02946164) | University of California, Berkeley | 2016-10-01 |